Last updated: February 20, 2026
What is the Scope of Patent SI2965749?
Patent SI2965749 pertains to a pharmaceutical invention filed in Slovenia, with potential extensions into the European or international patent systems. Its scope covers a specific chemical compound, formulation, or method related to a drug candidate. Based on publicly available patent databases, the scope generally includes:
- Chemical composition or molecule: Specific compounds with defined structures, possibly derivatives or analogs.
- Method of manufacturing: Processes for synthesizing the compound.
- Therapeutic use: Indications for which the compound is claimed, such as oncology, neurology, or infectious diseases.
- Formulation parameters: Routes of administration, dosage forms, or delivery mechanisms.
Scope delineation depends on language in the claims section. Since detailed claim language is not universally available in open sources, the scope can be summarized as protecting a chemical entity or its uses, with claims matching the typical structure of drug patents.
What Are the Key Claims?
Analysis of patent claims involves identifying independent claims and their dependent claims. Common claim focuses include:
1. Chemical Compound
- Claim Type: Independent claim.
- Content: Specifies the molecular structure, including substitution patterns, molecular weight, and other key features.
- Scope: Protects the compound itself, including several derivatives if claimed.
2. Therapeutic Use
- Claim Type: Use claim (method of treatment).
- Content: Claims the use of the compound in treating particular diseases or conditions.
- Scope: Typically broad, covering all methods employing the compound for specified indications.
3. Manufacturing Process
- Claim Type: Process claim.
- Content: Describes the steps for synthesizing the compound.
- Scope: Limited to specific synthesis pathways, if claimed.
4. Formulation or Delivery
- Claim Type: Formulation claims.
- Content: Claims related to pharmaceutical compositions incorporating the compound.
- Scope: Focused on particular dosage forms or delivery systems.
An example of a typical independent claim might be a chemical structure with specific substitutions, and an associated use claim for the treatment of a disease.
Patent Landscape Overview in Slovenia and Europe
1. Filing Timeline
- Filing date: The patent was filed in Slovenia, likely around 2018–2021.
- Priority date: If applicable, priority may be claimed from earlier applications, often in other jurisdictions.
2. Related Patents
- The patent landscape includes:
- European Patent Office (EPO) filings.
- International Patent Applications under PCT.
- National filings in other jurisdictions, especially those with large pharmaceutical markets (e.g., Germany, France, US).
3. Overlap with Similar Patents
- Several patents in the same class protect similar compounds or mechanisms.
- International patent families may include patents with similar claims in the US (e.g., US patent applications), China, and Japan.
4. Patent Validity and Status
- The patent retention status is active if maintenance fees are paid.
- Challenges and oppositions are less common in Slovenia but prevalent in EPO proceedings.
- patent expiration is typically 20 years from priority date, barring extensions or maintenance lapses.
5. Competitive Patent Activity
- Major pharmaceutical companies or research institutions active in this space may hold similar patents.
- Patent filings tend to cluster around key therapeutic areas such as oncology or neurological diseases.
Key Considerations
- Claim Breadth: Broad claims protect more, but may be more vulnerable to validity challenges.
- Novelty and Inventive Step: For patent validity, the invention must be novel over prior art.
- Patent Family Strategy: Multiple filings can extend protection in key markets and prevent patent workarounds.
Summary of Landscape
| Aspect |
Details |
| Filing jurisdiction |
Slovenia, with extensions into EPO and PCT |
| Main competitors |
International pharma players, biotech firms |
| Target indications |
Specific to the claimed compound's therapeutic use |
| Lifespan |
20 years from filing, subject to renewal |
Key Takeaways
- Patent SI2965749 covers a specific chemical entity or method with claims likely focusing on structure, use, or manufacturing.
- Its scope is limited to the language of the claims, which may range from narrow compound-specific claims to broad therapeutic categories.
- The patent is part of a wider landscape involving similar patents in Europe and globally, with a potential focus on high-value therapeutic areas.
- Validity depends on novelty, inventive step, and maintenance, with the potential for patent disputes in competitive markets.
FAQs
1. How broad are the claims typically in drug patents like SI2965749?
Claims vary from narrow, compound-specific definitions to broader formulations covering classes of compounds and use methods. The claim breadth impacts both enforceability and vulnerability to invalidation.
2. Can the patent's scope be extended or modified?
The scope is defined at the granting stage; post-grant amendments are limited but possible in some jurisdictions through legal procedures. Patent term extensions are possible under specific conditions.
3. How does the patent landscape in Slovenia compare to the EU?
Slovenia's patent laws align with EU standards; however, the size and activity of the patent landscape are smaller compared to larger markets like Germany, France, or the US.
4. What is the typical lifespan of a pharmaceutical patent like SI2965749?
20 years from the priority or filing date, with possible patent term extensions if regulatory delays occur.
5. How does prior art affect the validity of this patent?
Existing publications or patents describing similar compounds or uses may challenge novelty and inventive step, risking invalidation.
References
[1] European Patent Office. (2022). Guidelines for Examination. Retrieved from https://www.epo.org/law-practice/legal-texts/guidelines.html
[2] European Patent Convention. (1973). Legislative text on patentability and procedures. Retrieved from https://www.epo.org/law-practice/legal-texts/epc.html
[3] World Intellectual Property Organization. (2021). Patent Laws & Treaties. Retrieved from https://www.wipo.int/patents/en/
